Target Name: MIR301A
NCBI ID: G407027
Review Report on MIR301A Target / Biomarker Content of Review Report on MIR301A Target / Biomarker
MIR301A
Other Name(s): MicroRNA 301a | MIR301 | microRNA 301a | hsa-miR-301a-3p | hsa-miR-301a-5p | hsa-mir-301a | MIRN301A | mir-301a | MIRN301

MicroRNA 301a: A Target for Therapeutic Intervention

MicroRNA (miRNA) 301a is a non-coding RNA molecule that plays a crucial role in various biological processes in the human body. It is a key regulator of gene expression and has been implicated in a wide range of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

MIR301a is a small molecule that can interact with the protein translated from the miRNA. This interaction can cause the protein to either activate or repress its activity. This process is regulated by the structure and composition of the miRNA, as well as the presence of various chemical groups on the protein.

One of the unique features of MIR301a is its ability to self-loop, a process that allows the molecule to interact with itself in a feedback loop. This self-loop mechanism allows MIR301a to regulate its own activity and create a negative feedback loop that can modulate the activity of other miRNAs.

MIR301a has been shown to play a role in a wide range of biological processes, including cell growth, apoptosis, and inflammation. It has also been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and developmental disorders.

One of the key targets of MIR301a is the protein translated from the miRNA. This protein can either activate or repress the activity of MIR301a, depending on the presence of certain chemical groups on the protein. The presence of these chemical groups allows MIR301a to interact with the protein and either activate or repress its activity.

MIR301a has also been shown to interact with the microRNA 200a, which is also known as miRNA-181. These two molecules have been shown to work together in regulating gene expression and have been implicated in the development of various diseases, including cancer.

In addition to its role in gene expression, MIR301a has also been shown to play a role in the regulation of cellular processes such as cell adhesion, migration, and the cytoskeleton. It has also been shown to interact with various cellular signaling pathways, including the TGF-β pathway.

MIR301a has also been shown to play a role in the regulation of inflammation. It has been shown to interact with various signaling pathways involved in inflammation, including the NF-kappa-B pathway and the downstream signaling cascade.

MIR301a has also been shown to play a role in the regulation of cellular senescence, which is the process by which cells become less resistant to stress and undergo programmed cell death. It has been shown to interact with various signaling pathways involved in cellular senescence, including the p53 pathway.

In conclusion, MIR301a is a microRNA that plays a crucial role in various biological processes in the human body. Its ability to self-loop and interact with other miRNAs and proteins makes it an attractive drug target and a potential biomarker for a wide range of diseases. Further research is needed to fully understand the role of MIR301a in disease progression and the development of new therapeutic approaches.

Protein Name: MicroRNA 301a

The "MIR301A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR301A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR301B | MIR302A | MIR302B | MIR302C | MIR302D | MIR302E | MIR302F | MIR3059 | MIR3064 | MIR3065 | MIR3074 | MIR3085 | MIR30A | MIR30B | MIR30C1 | MIR30C2 | MIR30D | MIR30E | MIR31 | MIR3115 | MIR3116-1 | MIR3116-2 | MIR3117 | MIR3118-1 | MIR3118-2 | MIR3118-3 | MIR3118-4 | MIR3118-5 | MIR3118-6 | MIR3119-1 | MIR3119-2 | MIR3120 | MIR3121 | MIR3122 | MIR3123 | MIR3124 | MIR3125 | MIR3126 | MIR3127 | MIR3128 | MIR3129 | MIR3130-1 | MIR3130-2 | MIR3131 | MIR3132 | MIR3133 | MIR3134 | MIR3135A | MIR3135B | MIR3136 | MIR3137 | MIR3138 | MIR3139 | MIR3140 | MIR3141 | MIR3142 | MIR3142HG | MIR3143 | MIR3144 | MIR3145 | MIR3146 | MIR3147 | MIR3147HG | MIR3148 | MIR3149 | MIR3150A | MIR3150B | MIR3151 | MIR3152 | MIR3153 | MIR3154 | MIR3155A | MIR3155B | MIR3156-1 | MIR3156-2 | MIR3156-3 | MIR3157 | MIR3158-1 | MIR3158-2 | MIR3159 | MIR3160-1 | MIR3160-2 | MIR3161 | MIR3162 | MIR3163 | MIR3164 | MIR3165 | MIR3166 | MIR3167 | MIR3168 | MIR3169 | MIR3170 | MIR3171 | MIR3171HG | MIR3173 | MIR3174 | MIR3175 | MIR3176 | MIR3177 | MIR3178